References
- Asadikaram, G., et al., 2013. Hematological changes in opium addicted diabetic rats. International journal of high risk behaviors and addiction, 1(4), 141.
- Baar, A., and Graaff, B.M.T., 2008. Cognitive development at preschool-age of infants of drug-dependent mothers. Developmental medicine and child neurology, 36(12), 1063–1075.
- Bayani, M., et al., 2014. Opium consumption and lipid and glucose parameters in diabetic patients with acute coronary syndrome; a survey in northern Iran. Tunis medicale, 92, 496–500.
- Behzadi, M., Joukar, S., and Beik, A., 2018. Opioids and cardiac arrhythmia: a literature review. Medical principles and practice, 27(5), 401.
- Brown, J.N., et al., 2012. Morphine produces immunosuppressive effects in nonhuman primates at the proteomic and cellular levels. Molecular and cellular proteomics, 11(9), 605–618.
- Brown, S.M., et al., 2011. Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active. Anesthesiology, 115(6), 1251–1260.
- Burstein, Y., et al., 1979. Thrombocytosis and increased circulating platelet aggregates in newborn infants of polydrug users. The journal of pediatrics, 94(6), 895–899.
- Burstein, Y., et al., 1980. Thrombocytosis in the offspring of female mice receiving DL-methadone. Proceedings of the society for experimental biology and medicine. society for experimental biology and medicine (New York, N.Y.), 164(3), 275–279.
- Chum, H.H., et al., 2014. Antinociceptive effects of sustained-release buprenorphine in a model of incisional pain in rats (Rattus norvegicus). Journal of the American association for laboratory animal science, 53(2), 193–197.
- Coe, M.A., Lofwall, M.R., and Walsh, S.L., 2019. Buprenorphine pharmacology review: update on transmucosal and long-acting formulations. Journal of addiction medicine, 13(2), 93–103.
- Coyle, M.G., et al., 2018. Neonatal abstinence syndrome. Nature reviews disease primers, 4(1), 47.
- Curtin, L.I., et al., 2009. Evaluation of buprenorphine in a postoperative pain model in rats. Comparative medicine, 59(1), 60–71.
- Domeneh, B.H., Tavakoli, N., and Jafari, N., 2014. Blood lead level in opium dependents and its association with anemia: a cross-sectional study from the capital of Iran. Journal of research in medical sciences: the official journal of Isfahan university of medical sciences, 19(10), 939.
- Fischer, G., Johnson, R.E., and Eder, H., 2000. Treatment of opioid-dependent pregnant women with buprenorphine. Addiction, 95(2), 239–244.
- Geraghty, B., et al., 1997. Methadone levels in breast milk. Journal of human lactation, 13(3), 227–230.
- Gill, A.C., et al., 2007. Strabismus in infants of opiate‐dependent mothers. Acta paediatrica, 92(3), 379–385.
- Gopal, S., Tzeng, T.B., and Cowan, A., 2002. Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine. European journal of pharmaceutical sciences, 15(3), 287–293.
- Gozashti, M.H., et al., 2015. Fasting blood glucose and insulin level in opium addict versus non-addict individuals. Addiction and health, 7(1-2), 54.
- Griffin, B.A., et al., 2019. In utero exposure to norbuprenorphine, a major metabolite of buprenorphine, induces fetal opioid dependence and leads to neonatal opioid withdrawal syndrome. Journal of pharmacology and experimental therapeutics, 370(1), 9–17.
- Guarnieri, M., et al., 2012. Safety and efficacy of buprenorphine for analgesia in laboratory mice and rats. Lab animal, 41(11), 337.
- Guo, X., et al., 1994. Cognitive brain potential alterations in boys exposed to opiates: in utero and lifestyle comparisons. Addictive behaviors, 19(4), 429–441.
- Gupta, M., et al., 2012. Nystagmus and reduced visual acuity secondary to drug exposure in utero: long-term follow-up. Journal of pediatric ophthalmology and strabismus, 49(1), 58–63.
- Haghpanah, T., Afarinesh, M., and Divsalar, K., 2010. A review on hematological factors in opioid-dependent people (opium and heroin) after the withdrawal period. Addiction and health, 2(1–2), 9.
- Hish, J., et al., 2014. Effects of analgesic use on inflammation and hematology in a murine model of venous thrombosis. Journal of the American association for laboratory animal science, 53(5), 485–493.
- Huang, P., et al., 2001. Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist. Journal of pharmacology and experimental therapeutics, 297(2), 688–695.
- Ilett, K.F., et al., 2012. Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment. Breastfeeding medicine, 7(4), 269–274.
- Jansson, L.M., Velez, M., and Harrow, C., 2004. Methadone maintenance and lactation: a review of the literature and current management guidelines. Journal of human lactation, 20(1), 62–71.
- Javadi, H.R., et al., 2014. Opium dependency and in-hospital outcome of acute myocardial infarction. Medical journal of the Islamic Republic of Iran, 28, 122.
- Johnson, R., Jones, H.E., and Fischer, G., 2003. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug and alcohol dependence, 70(2), S87–S101.
- Johnson, R.E., et al., 2001. Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes. Drug and alcohol dependence, 63(1), 97–103.
- Kahila, H., et al., 2007. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome. Acta obstetricia et gynecologica Scandinavica, 86(2), 185–190.
- Kaur, P., et al., 2016. A methadone user with anaemia, skeletal pain and altered appearance. Tidsskrift for den norske legeforening, 136(10), 925.
- Kayemba-kays, S., and Laclyde, J.P., 2003. Buprenorphine withdrawal syndrome in newborns: a report of 13 cases. Addiction, 98(11), 1599–1604.
- Krans, E.E., et al., 2016. Factors associated with buprenorphine versus methadone use in pregnancy. Substance abuse, 37(4), 550–557.
- Liang, X., et al., 2016. Opioid system modulates the immune function: a review. Translational perioperative and pain medicine, 1(1), 5.
- Lindemalm, S., et al., 2009. Transfer of buprenorphine into breast milk and calculation of infant drug dose. Journal of human lactation, 25(2), 199–205.
- Mahmoodi, M., et al., 2012. Opium withdrawal and some blood biochemical factors in addicts’ individuals. Advances in biological chemistry, 2(2), 167–170.
- Mami, S., et al., 2011. Effect of opium addiction on some serum parameters in rabbit. Global veterinaria, 7(3), 310–314.
- Marquet, P., et al., 1997. Buprenorphine withdrawal syndrome in a newborn. Clinical pharmacology and therapeutics, 62(5), 569–571.
- Masoomi, M., Azdaki, N., and Shahouzehi, B., 2015. Elevated plasma homocysteine concentration in opium-addicted individuals. Addiction and health, 7(3-4), 149.
- McCarthy, J.J., and Posey, B.L., 2000. Methadone levels in human milk. Journal of human lactation, 16(2), 115–120.
- Messinger, D.S., et al., 2004. The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics, 113(6), 1677–1685.
- Mittal, L., 2014. Buprenorphine for the treatment of opioid dependence in pregnancy. The journal of perinatal and neonatal nursing, 28(3), 178–184.
- Mohammadi, A., et al., 2009. Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits. Experimental and toxicologic pathology, 61(2), 145–149.
- Mohammadi, A., et al., 2012. Effect of opium on lipid profile and expression of liver X receptor alpha (LXRα) in normolipidemic mouse. Food and nutrition sciences, 3, 249–254.
- Najafipour, H., and Beik, A., 2016. The impact of opium consumption on blood glucose, serum lipids and blood pressure, and related mechanisms. Frontiers in physiology, 7, 436.
- Najafipour, H., et al., 2010. Passive opium smoking does not have beneficial effect on plasma lipids and cardiovascular indices in hypercholesterolemic rabbits with ischemic and non-ischemic hearts. Journal of ethnopharmacology, 127(2), 257–263.
- Noormohammadi, A., et al., 2016. Buprenorphine versus methadone for opioid dependence in pregnancy. Annals of pharmacotherapy, 50(8), 666–672.
- O’Connor, A., et al., 2011. Observational study of buprenorphine treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes. Journal of American board of family medicine, 24(2), 194–201.
- Orum, M.H., et al., 2018. Complete blood count alterations due to the opioid use: what about the lymphocyte-related ratios, especially in monocyte to lymphocyte ratio and platelet to lymphocyte ratio? Journal of immunoassay and immunochemistry, 39(4), 365–376.
- Paul, J.A., et al., 2014. Development of auditory event‐related potentials in infants prenatally exposed to methadone. Developmental psychobiology, 56(5), 1119–1128.
- Pritham, U.A., Troese, M., and Stetson, A., 2007. Methadone and buprenorphine treatment during pregnancy: what are the effects on infants? Nursing for women's health, 11(6), 558–567.
- Rahimi, N., et al., 2014. Potential effect of opium consumption on controlling diabetes and some cardiovascular risk factors in diabetic patients. Addiction and health, 6(1-2), 1.
- Rosen, S.F., et al., 2019. Increased pain sensitivity and decreased opioid analgesia in T-cell-deficient mice and implications for sex differences. Pain, 160(2), 358–366.
- Sadeghian, S., et al., 2009. Effect of opium on glucose metabolism and lipid profiles in rats with streptozotocin-induced diabetes. Endokrynologia polska, 60(4), 258–262.
- Sanli, D.B., et al., 2015. Effect of different psychoactive substances on serum biochemical parameters. International journal of high risk behaviors and addiction, 4(2), e22702.
- Savov, Y., et al., 2006. Whole blood viscosity and erythrocyte hematometric indices in chronic heroin addicts. Clinical hemorheology and microcirculation, 35(1-2), 129–133.
- Schindler, S.D., et al., 2003. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction, 98(1), 103–110.
- Soykut, B., et al., 2013. Oxidative stress enzyme status and frequency of micronuclei in heroin addicts in Turkey. Toxicology mechanisms and methods, 23(9), 684–688.
- Sun, J., Guo, W., and Du, X., 2017. Buprenorphine differentially affects M1-and M2-polarized macrophages from human umbilical cord blood. European cytokine network, 28(2), 85–92.
- Tsai, L.C., and Doan, T.J., 2016. Breastfeeding among mothers on opioid maintenance treatment: a literature review. Journal of human lactation, 32(3), 521–529.
- van Baar, A.L., et al., 1994. Development after prenatal exposure to cocaine, heroin and methadone. Acta paediatrica, 404, 40–46.
- Wakeman, S.E., et al., 2019. Impact of fentanyl use on buprenorphine treatment retention and opioid abstinence. Journal of addiction medicine, 13(4), 253–257.
- White, A.J., et al., 2018. Peripheral inflammatory response to alpha-synuclein and endotoxin in Parkinson's disease. Frontiers in neurology, 9, 946.
- Wiles, J.R., et al., 2014. Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure. The journal of pediatrics, 165(3), 440–446.
- Yang, C., et al., 2017. Altered neuroendocrine immune responses, a two-sword weapon against traumatic inflammation. International journal of biological sciences, 13(11), 1409.